Kenneth Sherman

Kenneth E Sherman

Professor

Medical Sciences Building

7161

COM IM Digestive Diseases Division - 0595

Medical Sciences Building
231 Albert Sabin Way
Cincinnati, Ohio 45267

Education

Bachelor's Degree, Rutgers University 1976 (Biology)

Doctoral Degree, Rutgers University 1980 (Microbiology)

Medical Degree, George Washington University 1985

Research Fellowship , American Red Cross Blood Research Center 1982 (Transmissible Disease and Immunology Lab )

Residency, Tripler Army Medical Center 1988 (Internal Medicine )

Fellowship, Fitzsimons Army Medical Center 1991 (Gastroenterology/Hepatology )

Positions and Work Experience

1999 -2003 Director, Clinical Trials Research Office - Department of Medicine, University of Cincinnati, Cincinnati, OH

1998 -2004 Director, Hepatology & Liver Transplant Medicine Section, University of Cincinnati, Cincinnati, OH

1994 -2003 Program Director, GI Fellowship, University of Cincinnati, Cincinnati, OH

1994 -2001 Associate Professor of Medicine, University of Cincinnati College of Medicine, Cincinnati, OH

1992 -1994 Chief, Department of Clinical Investigation, Fitzsimons Army Medical Center,

1991 -1994 Staff Hepatologist/Gastroenterologist, Fitzsimons Army Medical Center,

1991 -1994 Assistant Clinical Professor of Medicine, University of Colorado School of Medicine,

1989 -1991 Assistant Clinical Professor of Medicine, University of Hawaii School of Medicine,

1988 -1989 Staff, Internal Medicine Service,

1981 -1982 Instructor , Microbiology, George Washington Unviersity School of Medicine,

1978 -1980 Adjunct Faculty in Biology, Middlesex College, Edison, NJ

Research and Practice Interests

Viral Hepatitis - Molecular Heterogeneity, Diagnosis and Treatment, Liver Disease in HIV Infected Patients, Drug Hepatotoxicity.

UC Health Clinical Focus

Gastroenterology

UC Health Specialities

Gastroenterology

Internal Medicine

Certifications

American Board of Internal Medicine (Gastroenterology)

02/15/2012

American Board of Internal Medicine

09/15/1988

Research Support

Grant: #5 U01 AI052748 Investigators:P Stock, KE Sherman 08-15-2003 -08-31-2011 NIH/NIAID Solid Organ Transplantation in HIV: A Multi Site Study Role:PI $290,272

Grant: #5 U01 AI052748 Investigators:P Stock, KE Sherman 08-15-2003 -08-31-2011 NIH/NIAID Pilot Study - HEV in HIV-Infected Liver Transplant Recipients Role:PI $10,800

Grant: #5 U01 AI69513 Investigators:C Fichtenbaum 12-01-2006 -11-30-2013 NIH/NIAID AIDS Clinical Trials Group (ACTG) Role:Co-I $1,196,010

Grant: #2 K24 DK 070528 Investigators:KE Sherman 03-01-2005 -02-28-2015 NIH/NIDDK Mentorship in Liver Disease $800,000

Grant: #5 R01 AI065256 Investigators:KE Sherman 04-15-2006 -03-31-2012 NIH/NIAID Antiretroviral Therapy and the Hepatitis C Virus $3,347,859

Grant: #5 R13 AI071925 Investigators:KE Sherman 07-01-2006 -05-31-2012 NIH/NIAID, NIDDK, NIDA, NIAAA Liver Disease and HIV Conference $74,800

Grant: #5 R21 AI081564 Investigators:JT Blackard 07-02-2009 -06-30-2012 NIH/NIAID Clinical Relevance of GB Virus C Interactions with HIV and Hepatitis C Virus in High Risk Women Role:Co-I $430,000

Grant: #1 R13 AI071925-01 Investigators:Sherman, Kenneth 07-01-2006 -06-30-2007 National Institute of Allergy and Infectious Diseases Liver Disease and HIV Conference Role:PI $25,000.00 Closed Level:Federal

Grant: #3563sc / U01 AI052748 Investigators:Sherman, Kenneth 08-15-2003 -08-31-2011 National Institute of Allergy and Infectious Diseases Solid Organ Transplantation in HIV: A Multi-Site Study Role:PI $316,611.00 Closed Level:Federal

Investigators:Sherman, Kenneth 01-01-2003 -06-30-2006 National Institute of Allergy and Infectious Diseases Social and Scientific Systems AACTG27.UCINN Role:PI $340,149.02 Closed Level:Federal

Grant: #1-N01-CP-01004-01-A0-S0-E0 Investigators:Sherman, Kenneth 08-15-2003 -10-31-2005 National Cancer Institute Evolution of HIV-1 env in HIV-1-infected Individuals With and Without HCV Coinfection Role:PI $61,400.00 Closed Level:Federal

Grant: #K24 DK070528 Investigators:Sherman, Kenneth 03-01-2005 -03-31-2010 National Inst of Diabetes and Digestive and Kidney Disease Mentorship in Liver Disease Role:PI $583,219.00 Closed Level:Federal

Grant: #R01 AI065256 Investigators:Sherman, Kenneth 04-01-2006 -03-31-2013 National Institute of Allergy and Infectious Diseases Antiretroviral Therapy and the Hepatitis C Virus Role:PI $3,419,727.00 Active Level:Federal

Investigators:Sherman, Kenneth 06-01-2001 -05-31-2006 National Institute of Allergy and Infectious Diseases HCV Genomic Variability in HIV Infected Hemophiliacs Role:PI $2,866,251.04 Closed Level:Federal

Grant: #5-U01-AI-38858-06-A0-S0-E0 Investigators:Sherman, Kenneth 10-01-2000 -12-31-2002 National Institute of Allergy and Infectious Diseases Adult ACTG Central Group Role:PI $301,131.00 Closed Level:Federal

Grant: #2002-UC-14-01-A0-S0-E0 Investigators:Sherman, Kenneth 09-01-2001 -03-31-2003 Social & Scientific Systems, Inc. Social Scientific Systems AACTG.27.NW205.01 Role:PI $66,618.00 Closed Level:Industry

Grant: #5-97-CY-50391-02-A0-S0-E0 Investigators:Sherman, Kenneth 09-27-1997 -05-01-2001 National Cancer Institute HCV Quasispecies Variability in HIV/HCV Co-Infected Role:PI $90,963.00 Closed Level:Federal

Grant: #1-U01-AI-38858-01-A0-S0-E0 Investigators:Sherman, Kenneth 05-01-1999 -09-30-2000 National Institute of Allergy and Infectious Diseases Prevalence of Hepatitis C Virus (HCV) and Distribution of Genotypes in a Representative ACTG Cohort Role:PI $91,379.00 Closed Level:Federal

Grant: #R03HS10366-01-A0-S0-E0 Investigators:Sherman, Kenneth 09-30-1999 -03-31-2001 Agency for Healthcare Research and Quality Health Utilities in Hepatitis C Infected Patients Role:PI $76,072.00 Closed Level:Federal

Grant: #R13 AI071925 Investigators:Russell, Betsy; Sherman, Kenneth 07-01-2006 -03-31-2012 National Institute of Allergy and Infectious Diseases Liver Disease and HIV Role:PI $73,986.00 Closed Level:Federal

Grant: #R21 AI081564 Investigators:Blackard, Jason; Sherman, Kenneth; Welge, Jeffrey 07-02-2009 -06-30-2012 National Institute of Allergy and Infectious Diseases Clinical Relevance of GB Virus C Interactions with HIV and Hepatitis C Virus in High Risk Women Role:Collaborator $429,788.00 Closed Level:Federal

Grant: #3 K24 DK070528-05S1 Investigators:Sherman, Kenneth 01-15-2010 -12-31-2010 National Inst of Diabetes and Digestive and Kidney Disease Mentorship in Liver Disease Role:PI $47,000.00 Closed Level:Federal

Grant: #K24 DK070528 Investigators:Sherman, Kenneth 04-01-2010 -02-28-2015 National Inst of Diabetes and Digestive and Kidney Disease Mentorship in Liver Disease Role:PI $631,260.00 Active Level:Federal

Grant: #Merck 38879 Investigators:Shata, Mohamed Tarek; Sherman, Kenneth 03-30-2011 -03-30-2013 Merck Sharp & Dohme Corp Exploring the Role of Gut-associated Th17 in Microbial Translocation in HIV and HCV/HIV Coinfected Patients Role:Collaborator $160,761.00 Closed Level:Industry

Grant: #SRS 007663 Investigators:Eckman, Mark; Sherman, Kenneth 10-01-2011 -08-13-2013 Merck Sharp & Dohme Corp The Cost Effectiveness of Screening for Chronic Hepatitis C Infection in the United States Role:PI $137,994.00 Active Level:Industry

Grant: #SRS 007747 Investigators:Lin, Ming; Sherman, Kenneth 02-01-2012 -01-31-2013 Bristol-Myers Squibb Co. Development of Novel Methodologies for the Detection of IL28B Single-Nucleotide Polymorphisms in HCV-Infected Patients Role:PI $20,000.00 Active Level:Industry

Grant: #SRS 007837 Investigators:Blackard, Jason; Shata, Mohamed Tarek; Sherman, Kenneth; Ying, Jun 02-15-2012 -02-15-2014 Merck Sharp & Dohme Corp Evaluating the Role of the Immune Responses in the Emergence of HCV NS3 Resistance Mutations During Protease Inhibitor Therapy Role:Collaborator $231,044.00 Active Level:Industry

Grant: #R13AI071925 Investigators:Sherman, Kenneth 04-01-2012 -03-31-2015 National Institute of Allergy and Infectious Diseases Liver Disease and HIV Role:PI $45,900.00 Active Level:Federal

Grant: #BRS-ACURE-S-12-000068-002483 / UM1 AI068636-06 Investigators:Sherman, Kenneth 12-01-2011 -05-31-2012 National Institute of Allergy and Infectious Diseases A Prospective, Phase III, Open-Label Study of Boceprevir, Pegylated-Interferon Alfa 2b and Ribavirin in HCV/HIV Coinfected Subjects Role:PI $10,736.00 Closed Level:Federal

Grant: #BRS-ACURE-S-12-002522 Investigators:Sherman, Kenneth 03-01-2012 -05-31-2014 Merck & Co., Inc. ACTG Protocol A5294 - BIRTH - A Prospective, Phase III, Open-Label Study of Boceprevir, Pegylated-Interferon Alfa 2b and Ribavirin in HCV/HIV Coinfected Subjects Role:PI $39,680.00 Active Level:Industry

Grant: #R34HL109334 Investigators:Sherman, Kenneth 05-25-2012 -04-30-2014 National Heart, Lung and Blood Institute Viral Kinetic Models of HCV Clearance in Hemophiliacs Treated with Telaprevir Role:PI $712,728.00 Active Level:Federal

Grant: #Req No. 2715199 HHSN272201200811P Investigators:Sherman, Kenneth 07-01-2012 -06-30-2014 National Institute of Allergy and Infectious Diseases The Use of Chemokine Receptor 5 (CCR5) Blockade Using a Monoclonal Antibody to Reverse Liver Fibrosis in HIV-infected Subjects Role:PI $50,000.00 Active Level:Federal

Grant: #108400 \ UM1A1068636 Investigators:Blackard, Jason; Sherman, Kenneth 06-01-2012 -12-31-2013 National Institute of Allergy and Infectious Diseases Characterization of HCV Resistance Associated Variants in Liver Tissue Role:PI $187,435.00 Active Level:Federal

Grant: #U01FD004573 Investigators:Alloway, Rita; Kaiser, Tiffany; Sherman, Kenneth; Shields, Adele; Woodle, Ervin Steve 09-15-2012 -09-14-2015 Food and Drug Administration Pharmacokinetic Studies of Tacrolimus in Transplant Patients Role:Collaborator $2,691,189.00 Active Level:Federal

Grant: #108269/AI068636 Investigators:Sherman, Kenneth 06-01-2012 -05-31-2014 National Institute of Allergy and Infectious Diseases Protocol A5294 BIRTH - A Prospective, Phase III, Open-Label Study of Boceprevir, Pegylated-Interferon Alfa 2b And Ribavirin In HCV/HIV Coinfected Subjects Role:PI $31,334.00 Active Level:Federal

Grant: #AI463-980 Investigators:Sherman, Kenneth 08-01-2013 -07-31-2014 Bristol-Myers Squibb Co. Hepatitis C Virus Prevalence: Role of the Emergency Department in Screening Role:PI $20,000.00 Active Level:Industry

Grant: #PRO12060248 (HOTS) Investigators:Sherman, Kenneth 11-01-2013 -12-31-2014 Health Resources and Services Administration Hemophilia Liver Transplant Observational (HOT) Study Role:PI $3,348.00 Awarded Level:Federal

Grant: #110237 / AI068636-08 Investigators:Sherman, Kenneth 01-01-2014 -11-30-2014 National Institute of Allergy and Infectious Diseases AIDS Clinical Trial Group Network - Co-Chair on ACTG Protocol A5294 Role:PI $17,961.00 Active Level:Federal

Grant: #R56 AI065256 Investigators:Sherman, Kenneth 07-01-2014 -06-30-2015 National Institute of Allergy and Infectious Diseases Antiretroviral Therapy and Hepatic Injury Role:PI $524,620.00 Awarded Level:Federal

Grant: #CW432593 Investigators:Sherman, Kenneth 01-01-2015 -12-31-2015 MedImmune Immune Checkpoint Markers in Patients with Chronic Liver Disease Role:PI $151,594.55 Active Level:Industry

Grant: #R01DK108362 Investigators:Blackard, Jason; Shata, Mohamed Tarek; Sherman, Kenneth 09-23-2015 -08-31-2020 National Inst of Diabetes and Digestive and Kidney Disease Hepatitis E in HIV-Infected Patients Role:PI $274,999.00 Awarded Level:Federal

Grant: #R01 AI065256 Investigators:Blackard, Jason; Shata, Mohamed Tarek; Sherman, Kenneth 02-15-2016 -01-31-2020 National Institute of Allergy and Infectious Diseases HIV Antiretroviral Therapy and Hepatic Injury Role:PI $2,124,402.93 Awarded Level:Federal

Grant: #53186 Investigators:Sherman, Kenneth 09-01-2015 -08-31-2016 Merck Sharp & Dohme Corp Ultra-deep Sequencing of NS5A Resistance Variants in HCV/HIV Coinfected Patients Role:PI $78,073.20 Active Level:Industry

Grant: #800005519-01UG/U01DA040381 Investigators:Sherman, Kenneth 09-15-2015 -05-31-2016 National Institute on Drug Abuse Cohort Studies of HIV/AIDS and Substance Abuse in Miami Role:PI $161,007.00 Awarded Level:Federal

Grant: #UFDSP00011086 / PCORI HPC-1503-27891 Investigators:Sherman, Kenneth 03-01-2016 -02-28-2021 Patient-Centered Outcomes Research Institute THE PRIORITIZE STUDY: A Pragmatic, Randomized Study of Oral Regimens for Hepatitis C: Transforming Decision-Making for Patients, Providers, and Stakeholders Role:PI $258,208.50 Awarded Level:Private Non-Profit

Grant: #115113 / UM1 AI068636 Investigators:Sherman, Kenneth 06-01-2016 -11-30-2016 National Institute of Allergy and Infectious Diseases Prevalence and Significance of PNPLA3 Gene Polymorphisms in HCV/HIV Infected Persons Role:PI $70,546.28 Active Level:Federal

Grant: #2016 ACG Investigators:Anwar, Nadeem; Bari, Khurram; Kaiser, Tiffany; Shah, Shimul; Sherman, Kenneth 07-01-2016 -06-30-2017 American College of Gastroenterology A Pilot Study to Evaluate the Safety and Efficacy of Budesonide as an Alternative to Prednisone for Liver Transplant Immune Suppression Role:Collaborator $10,000.00 Active Level:Private Non-Profit

Grant: #R13AI071925 Investigators:Sherman, Kenneth 09-02-2016 -08-31-2017 National Institute of Allergy and Infectious Diseases Liver Disease and HIV Role:PI $40,000.00 Active Level:Federal

Grant: #MISP 55908 Investigators:Eckman, Mark; Paterno, Flavio; Sherman, Kenneth; Thakar, Charuhas; Woodle, Ervin Steve 05-01-2017 -05-01-2019 Merck Sharp & Dohme Corp Timing of Treatment for Chronic Hepatitis C Infection in Patients with End Stage Rengal Disease Awaiting Transplantation Role:PI $96,149.00 Active Level:Industry

Grant: #113237 / A5329 Investigators:Sherman, Kenneth 11-01-2016 -06-29-2018 AbbVie, Inc. Interferon-Free Therapy for Chronic Hepatitis C Virus Genotype 1 Infection in Patients with HIV-1 Coinfection Receiving Concurrent Antiretroviral Therapy Role:PI $9,510.00 Active Level:Industry

Grant: #Independent Contractor Agreement 511 Investigators:Eckman, Mark; Sherman, Kenneth 03-12-2018 -09-30-2018 CDC Foundation The Cost Effectiveness of Screening for Chronic Hepatitis C Infection in the United States: An Update for 2018 Role:PI $30,000.00 Awarded Level:Private Non-Profit

Grant: #1802163 / DA143396 Investigators:Sherman, Kenneth 02-01-2018 -05-31-2022 National Institute on Drug Abuse Immune correlates of long-term success with DAA therapy in HCV/HIV infected people who inject drugs Role:PI $23,412.00 Active Level:Federal

Grant: #R61DA048439 Investigators:Blackard, Jason; Brown, Jennifer; Lyons, Michael; Medvedovic, Mario; Sherman, Kenneth 03-01-2019 -12-31-2021 National Institutes of Health Omics analysis of HIV during synthetic opioid exposure Role:Collaborator $573,135.00 Awarded Level:Federal

Grant: #Clinical Site Agreement Investigators:Sherman, Kenneth 01-01-2018 -12-31-2019 Brigham and Women's Hospital, Inc. A randomized, placebo-controlled pilot study of sulfasalazine for the treatment of Primary Sclerosing Cholangitis (SHIP) Role:PI $10,500.00 Awarded Level:Private Non-Profit

Grant: #1560GWB207 / UM1AI068636 Investigators:Sherman, Kenneth 12-01-2018 -11-30-2019 National Institute of Allergy and Infectious Diseases ACTG Protocol Chair Salary Support - Leadership and Operations Center (LOC), AIDS Clinical Trials Group (ACTG) Role:PI $5,600.00 Awarded Level:Federal

Grant: #ACTG CORE / AI069501 Investigators:Fichtenbaum, Carl; Huaman, Moises; Sherman, Kenneth 12-01-2019 -11-30-2020 National Institute of Allergy and Infectious Diseases ACTG Core Funds, PF & HPTN Role:Collaborator $1,110,207.00 Awarded Level:Federal

Publications

Peer Reviewed Publications

Eckman, Mark H; Kaiser, Tiffany E; Sherman, Kenneth E (2011. )The Cost-effectiveness of Screening for Chronic Hepatitis B Infection in the United States.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, ,52 (11 ),1294-306

Blackard, Jason T; Ma, Gang; Martin, Christina M; Rouster, Susan D; Shata, M Tarek; Sherman, Kenneth E (2011. )HIV Variability in the Liver and Evidence of Possible Compartmentalization.AIDS research and human retroviruses, ,

Taylor, Lynn E; Holubar, Marisa; Wu, Kunling; Bosch, Ronald J; Wyles, David L; Davis, John A; Mayer, Kenneth H; Sherman, Kenneth E; Tashima, Karen T (2011. )Incident hepatitis C virus infection among US HIV-infected men enrolled in clinical trials.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, ,52 (6 ),812-8

Blackard, Jason T; Welge, Jeffrey A; Taylor, Lynn E; Mayer, Kenneth H; Klein, Robert S; Celentano, David D; Jamieson, Denise J; Gardner, Lytt; Sherman, Kenneth E (2011. )HIV mono-infection is associated with FIB-4 - A noninvasive index of liver fibrosis - in women.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, ,52 (5 ),674-80

Schmeltzer, Paul; Sherman, Kenneth E (2010. )Occult hepatitis B: clinical implications and treatment decisions.Digestive diseases and sciences, ,55 (12 ),3328-35

Sulkowski, Mark S; Shiffman, Mitchell L; Afdhal, Nezam H; Reddy, K Rajender; McCone, Jonathan; Lee, William M; Herrine, Steven K; Harrison, Stephen A; Poordad, F Fred; Koury, Kenneth; Deng, Weiping; Noviello, Stephanie; Pedicone, Lisa D; Brass, Clifford A; Albrecht, Janice K; McHutchison, John G (2010. )Hepatitis C virus treatment-related anemia is associated with higher sustained virologic response rate.Gastroenterology, ,139 (5 ),1602-11, 1611.e1

Blackard, Jason T; Ma, Gang; Limketkai, Berkeley N; Welge, Jeffrey A; Dryer, Peter D; Martin, Christina M; Hiasa, Yoichi; Taylor, Lynn E; Mayer, Kenneth H; Jamieson, Denise J; Sherman, Kenneth E (2010. )Variability of the polymerase gene (NS5B) in hepatitis C virus-infected women.Journal of clinical microbiology, ,48 (11 ),4256-9

Sherman, Kenneth E; Andersen, Janet W; Butt, Adeel A; Umbleja, Triin; Alston, Beverly; Koziel, Margaret J; Peters, Marion G; Sulkowski, Mark; Goodman, Zachary D; Chung, Raymond T (2010. )Sustained Long-Term Antiviral Maintenance Therapy in HCV/HIV-Coinfected Patients (SLAM-C).Journal of acquired immune deficiency syndromes (1999), ,

Kemmer, Nyingi M; Sherman, Kenneth E (2010. )Hepatitis C-related arthropathy: Diagnostic and treatment considerations. The Journal of musculoskeletal medicine, ,27 (9 ),351-354

Sherman, Kenneth E (2010. )Thymosin alpha 1 for treatment of hepatitis C virus: promise and proof.Annals of the New York Academy of Sciences, ,1194 ,136-40

McHutchison, John; Goodman, Zachary; Patel, Keyur; Makhlouf, Hala; Rodriguez-Torres, Maribel; Shiffman, Mitchell; Rockey, Don; Husa, Petr; Chuang, Wan-Long; Levine, Robert; Jonas, Mark; Theodore, Dickens; Brigandi, Richard; Webster, Alison; Schultz, Margaret; Watson, Helen; Stancil, Britt; Gardner, Stephen (2010. )Farglitazar lacks antifibrotic activity in patients with chronic hepatitis C infection.Gastroenterology, ,138 (4 ),1365-73, 1373.e1-2

Sherman, Kenneth E; Soriano, Vincent; Chung, Raymond T (2010. )Human immunodeficiency virus and liver disease: conference proceedings.Hepatology (Baltimore, Md.), ,51 (3 ),1046-54

Sherman, Kenneth E; Rouster, Susan D; Stanford, Sandra; Blackard, Jason T; Shire, Norah; Koziel, Margaret; Peters, Marion; Chung, Raymond T (2010. )Hepatitis C virus (HCV) quasispecies complexity and selection in HCV/HIV-coinfected subjects treated with interferon-based regimens.The Journal of infectious diseases, ,201 (5 ),712-9

Dryer, Peter D; Limketkai, Berkeley N; Martin, Christina M; Ma, Gang; Sherman, Kenneth E; Taylor, Lynn E; Mayer, Kenneth H; Jamieson, Denise J; Blackard, Jason T (2009. )Screening for hepatitis C virus non-nucleotide resistance mutations in treatment-naive women.The Journal of antimicrobial chemotherapy, ,64 (5 ),945-8

Blackard, Jason T; Rouster, Susan D; Nady, Soad; Galal, Gehan; Marzuuk, Naglaa; Rafaat, Marwaa M; Daef, Enas; El Din, Salwa Seif; Purcell, Robert H; Emerson, Suzanne U; Sherman, Kenneth E; Shata, M Tarek (2009. )Genotypic characterization of symptomatic hepatitis E virus (HEV) infections in Egypt.Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology, ,46 (2 ),140-4

Martin, Christina M; Welge, Jeffrey A; Shire, Norah J; Shata, Mohamed T; Sherman, Kenneth E; Blackard, Jason T (2009. )Cytokine expression during chronic versus occult hepatitis B virus infection in HIV co-infected individuals.Cytokine, ,47 (3 ),194-8

Sherman, Kenneth; Belkin, Igor M; Friedland, Kevin D; O'Reilly, John; Hyde, Kimberly (2009. )Accelerated warming and emergent trends in fisheries biomass yields of the world's large marine ecosystems. Ambio, ,38 (4 ),215-24

Poynard, Thierry; Colombo, Massimo; Bruix, Jordi; Schiff, Eugene; Terg, Ruben; Flamm, Steven; Moreno-Otero, Ricardo; Carrilho, Flair; Schmidt, Warren; Berg, Thomas; McGarrity, Thomas; Heathcote, E Jenny; Gonçales, Fernando; Diago, Moises; Craxi, Antonio; Silva, Marcelo; Bedossa, Pierre; Mukhopadhyay, Pabak; Griffel, Louis; Burroughs, Margaret; Brass, Clifford; Albrecht, Janice (2009. )Peginterferon alfa-2b and ribavirin: effective in patients with hepatitis C who failed interferon alfa/ribavirin therapy.Gastroenterology, ,136 (5 ),1618-28.e2

Shire, Norah J; Rao, Marepalli B; Succop, Paul; Buncher, C Ralph; Andersen, Janet A; Butt, Adeel A; Chung, Raymond T; Sherman, Kenneth E (2009. )Improving noninvasive methods of assessing liver fibrosis in patients with hepatitis C virus/human immunodeficiency virus co-infection.Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association, ,7 (4 ),471-80, 480.e1-2

Atiq, Muslim; Shire, Norah J; Barrett, Anna; Rouster, Susan D; Sherman, Kenneth E; Shata, Mohamed T (2009. )Hepatitis E virus antibodies in patients with chronic liver disease. Emerging infectious diseases, ,15 (3 ),479-81

Gordon, Stuart C; Sherman, Kenneth E (2009. )Treatment of HBV/HCV coinfection: releasing the enemy within.Gastroenterology, ,136 (2 ),393-6

Kemmer, Nyingi; Sherman, Kenneth E (2008. )What is the impact of HIV infection on survival after liver transplantation?.Nature clinical practice. Gastroenterology & hepatology, ,5 (8 ),426-7

Blackard, Jason T; Shata, M Tarek; Shire, Norah J; Sherman, Kenneth E (2008. )Acute hepatitis C virus infection: a chronic problem.Hepatology (Baltimore, Md.), ,47 (1 ),321-31

Sherman, Kenneth E; Fleischer, Russell; Laessig, Katherine; Murray, Jeffrey; Tauber, William; Birnkrant, Debra (2007. )Development of novel agents for the treatment of chronic hepatitis C infection: Summary of the FDA Antiviral Products Advisory Committee recommendations.Hepatology (Baltimore, Md.), ,46 (6 ),2014-20

Sherman, Kenneth E; Peters, Marion; Koziel, Margaret James (2007. )HIV and liver disease forum: conference proceedings.Hepatology (Baltimore, Md.), ,45 (6 ),1566-77

Alatrakchi, Nadia; Graham, Camilla S; van der Vliet, Hans J J; Sherman, Kenneth E; Exley, Mark A; Koziel, Margaret James (2007. )Hepatitis C virus (HCV)-specific CD8+ cells produce transforming growth factor beta that can suppress HCV-specific T-cell responses.Journal of virology, ,81 (11 ),5882-92

Sherman, Kenneth E; Goodman, Zachary D; Sullivan, Sara T; Faris-Young, Sima (2007. )Liver biopsy in cirrhotic patients.The American journal of gastroenterology, ,102 (4 ),789-93

Blackard, Jason T; Kang, Minhee; St Clair, J Benjamin; Lin, Wenyu; Kamegaya, Yoshitaka; Sherman, Kenneth E; Koziel, Margaret James; Peters, Marion G; Andersen, Janet; Chung, Raymond T (2007. )Viral factors associated with cytokine expression during HCV/HIV co-infection.Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research, ,27 (4 ),263-9

Shire, Norah J; Rouster, Susan D; Stanford, Sandra D; Blackard, Jason T; Martin, Christina M; Fichtenbaum, Carl J; Sherman, Kenneth E (2007. )The prevalence and significance of occult hepatitis B virus in a prospective cohort of HIV-infected patients.Journal of acquired immune deficiency syndromes (1999), ,44 (3 ),309-14

Blackard, Jason T; Sherman, Kenneth E (2007. )Hepatitis C virus coinfection and superinfection.The Journal of infectious diseases, ,195 (4 ),519-24

Sherman, Kenneth E (2007. )New paradigms in the management of hepatitis C virus co-infections.Nature clinical practice. Gastroenterology & hepatology, ,4 Suppl 1 ,S10-6

Shire, Norah J; Horn, Paul S; Rouster, Susan D; Stanford, Sandra; Eyster, M Elaine; Sherman, Kenneth E (2006. )HCV kinetics, quasispecies, and clearance in treated HCV-infected and HCV/HIV-1-coinfected patients with hemophilia.Hepatology (Baltimore, Md.), ,44 (5 ),1146-57

Peters, Marion G; Andersen, Janet; Lynch, Patrick; Liu, Tun; Alston-Smith, Beverly; Brosgart, Carol L; Jacobson, Jeffrey M; Johnson, Victoria A; Pollard, Richard B; Rooney, James F; Sherman, Kenneth E; Swindells, Susan; Polsky, Bruce (2006. )Randomized controlled study of tenofovir and adefovir in chronic hepatitis B virus and HIV infection: ACTG A5127.Hepatology (Baltimore, Md.), ,44 (5 ),1110-6

Blackard, Jason T; Kang, Minhee; Sherman, Kenneth E; Koziel, Margaret James; Peters, Marion G; Chung, Raymond T (2006. )Effects of HCV treatment on cytokine expression during HCV/HIV coinfection.Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research, ,26 (11 ),834-8

Mann, Elizabeth A; Stanford, Sandra; Sherman, Kenneth E (2006. )Prevalence of mutations in hepatitis C virus core protein associated with alteration of NF-kappaB activation.Virus research, ,121 (1 ),51-7

Schwarze-Zander, Carolynne; Blackard, Jason T; Zheng, Hui; Addo, Marylyn M; Lin, Wenyu; Robbins, Gregory K; Sherman, Kenneth E; Zdunek, Dietmar; Hess, Georg; Chung, Raymond T (2006. )GB virus C (GBV-C) infection in hepatitis C virus (HCV)/HIV-coinfected patients receiving HCV treatment: importance of the GBV-C genotype.The Journal of infectious diseases, ,194 (4 ),410-9

Blackard, Jason T; Kemmer, Nyingi; Sherman, Kenneth E (2006. )Extrahepatic replication of HCV: insights into clinical manifestations and biological consequences.Hepatology (Baltimore, Md.), ,44 (1 ),15-22

Atiq, Muslim; Neff, Guy W; Buell, Joseph; Kemmer, Nyingi; Rudich, Steven; Weber, Fred; Sherman, Kenneth (2006. )Rhabdomylysis transference during liver transplantation.Transplantation, ,81 (9 ),1359-60

Mandac, Jamie C; Chaudhry, Sonal; Sherman, Kenneth E; Tomer, Yaron (2006. )The clinical and physiological spectrum of interferon-alpha induced thyroiditis: toward a new classification.Hepatology (Baltimore, Md.), ,43 (4 ),661-72

Graham, Camilla S; Wells, Annalee; Liu, Tun; Sherman, Kenneth E; Peters, Marion; Chung, Raymond T; Bhan, Atul K; Andersen, Janet; Koziel, Margaret James (2006. )Relationships between cellular immune responses and treatment outcomes with interferon and ribavirin in HIV/hepatitis C virus co-infection.AIDS (London, England), ,20 (3 ),345-51

Mrus, Joseph M; Sherman, Kenneth E; Leonard, Anthony C; Sherman, Susan N; Mandell, Karen L; Tsevat, Joel (2006. )Health values of patients coinfected with HIV/hepatitis C: are two viruses worse than one? .Medical care, ,44 (2 ),158-66

Shire, Norah J; Welge, Jeffrey A; Sherman, Kenneth E (2006. )Efficacy of inactivated hepatitis A vaccine in HIV-infected patients: a hierarchical bayesian meta-analysis.Vaccine, ,24 (3 ),272-9

Sherman, Kenneth E; Shire, Norah J; Cernohous, Paul; Rouster, Susan D; Omachi, Janice H; Brun, Scott; Da Silva, Barbara (2005. )Liver injury and changes in hepatitis C Virus (HCV) RNA load associated with protease inhibitor-based antiretroviral therapy for treatment-naive HCV-HIV-coinfected patients: lopinavir-ritonavir versus nelfinavir.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, ,41 (8 ),1186-95

Sherman, Kenneth E (2005. )Treatment of hepatitis C virus and human immunodeficiency virus co-infection. Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association, ,3 (10 Suppl 2 ),S118-21

Chun, Sooyun; Sherman, Kenneth E (2005. )Treatment of hepatitis C virus/HIV coinfection.Clinics in liver disease, ,9 (3 ),525-33, ix

Shire, Norah J; Sherman, Kenneth E (2005. )Clinical trials of treatment for hepatitis C virus infection in HIV-infected patients: past, present, and future.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, ,41 Suppl 1 ,S63-8

Graham, Camilla S; Wells, Annalee; Liu, Tun; Sherman, Kenneth E; Peters, Marion; Chung, Raymond T; Bhan, Atul K; Andersen, Janet; Koziel, Margaret James (2005. )Antigen-specific immune responses and liver histology in HIV and hepatitis C coinfection. AIDS (London, England), ,19 (8 ),767-73

Alatrakchi, Nadia; Graham, Camilla S; He, Qi; Sherman, Kenneth E; Koziel, Margaret James (2005. )CD8+ cell responses to hepatitis C virus (HCV) in the liver of persons with HCV-HIV coinfection versus HCV monoinfection.The Journal of infectious diseases, ,191 (5 ),702-9

Glesby, Marshall J; Bassett, Roland; Alston-Smith, Beverly; Fichtenbaum, Carl; Jacobson, Elizabeth L; Brass, Clifford; Owens, Susan; Sulkowski, Mark; Race, Elizabeth M; Sherman, Kenneth E (2005. )Pilot study of low-dose interleukin-2, pegylated interferon-alpha 2b, and ribavirin for the treatment of hepatitis C virus infection in patients with HIV infection.The Journal of infectious diseases, ,191 (5 ),686-93

Lienesch, Douglas; Morris, Robert; Metzger, Allan; Debuys, Paige; Sherman, Kenneth (2005. )Absence of cyclic citrullinated peptide antibody in nonarthritic patients with chronic hepatitis C infection. The Journal of rheumatology, ,32 (3 ),489-93

Sherman, Kenneth E; Shire, Norah J; Rouster, Susan D; Peters, Marion G; James Koziel, Margaret; Chung, Raymond T; Horn, Paul S (2005. )Viral kinetics in hepatitis C or hepatitis C/human immunodeficiency virus-infected patients. Gastroenterology, ,128 (2 ),313-27

Qin, Hongxing; Shire, Norah J; Keenan, Erica D; Rouster, Susan D; Eyster, M Elaine; Goedert, James J; Koziel, Margaret James; Sherman, Kenneth E (2005. )HCV quasispecies evolution: association with progression to end-stage liver disease in hemophiliacs infected with HCV or HCV/HIV.Blood, ,105 (2 ),533-41

Shire, Norah J; Sherman, Kenneth E (2005. )Management of HBV/HIV-coinfected Patients.Seminars in liver disease, ,25 Suppl 1 ,48-57

Sherman, Kenneth E; Sherman, Susan N; Chenier, Thomas; Tsevat, Joel (2004. )Health values of patients with chronic hepatitis C infection.Archives of internal medicine, ,164 (21 ),2377-82

Zucker, Stephen D; Horn, Paul S; Sherman, Kenneth E (2004. )Serum bilirubin levels in the U.S. population: gender effect and inverse correlation with colorectal cancer.Hepatology (Baltimore, Md.), ,40 (4 ),827-35

Morelli, Michael S; Rouster, Susan D; Giannella, Ralph A; Sherman, Kenneth E (2004. )Clinical application of polymerase chain reaction to diagnose Clostridium difficile in hospitalized patients with diarrhea. Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association, ,2 (8 ),669-74

Keenan, Erica D; Rouster, Susan D; Shire, Norah J; Horn, Paul S; Sherman, Kenneth E (2004. )Complexity and diversity of hepatitis C virus RNA in african americans and whites: analysis of the envelope-coding domain.The Journal of infectious diseases, ,190 (3 ),511-4

Chung, Raymond T; Andersen, Janet; Volberding, Paul; Robbins, Gregory K; Liu, Tun; Sherman, Kenneth E; Peters, Marion G; Koziel, Margaret J; Bhan, Atul K; Alston, Beverly; Colquhoun, Dodi; Nevin, Tom; Harb, George; van der Horst, Charles (2004. )Peginterferon Alfa-2a plus ribavirin versus interferon alfa-2a plus ribavirin for chronic hepatitis C in HIV-coinfected persons.The New England journal of medicine, ,351 (5 ),451-9

Graham, Camilla S; Curry, Michael; He, Qi; Afdhal, Nezam; Nunes, David; Fleming, Catherine; Horsburgh, Robert; Craven, Donald; Sherman, Kenneth E; Koziel, Margaret James (2004. )Comparison of HCV-specific intrahepatic CD4+ T cells in HIV/HCV versus HCV.Hepatology (Baltimore, Md.), ,40 (1 ),125-32

Shire, Norah J; Rouster, Susan D; Rajicic, Natasa; Sherman, Kenneth E (2004. )Occult hepatitis B in HIV-infected patients. Journal of acquired immune deficiency syndromes (1999), ,36 (3 ),869-75

Zucker, Stephen D; Sherman, Kenneth E (2004. )Beyond interferon for hepatitis C: living in the present while hoping for the future. Gastroenterology, ,126 (5 ),1487-8

Fleischer, Russell; Boxwell, Debra; Sherman, Kenneth E (2004. )Nucleoside analogues and mitochondrial toxicity.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, ,38 (8 ),e79-80

Blackard, Jason T; Yang, Yijun; Bordoni, Paola; Sherman, Kenneth E; Chung, Raymond T (2004. )Hepatitis C virus (HCV) diversity in HIV-HCV-coinfected subjects initiating highly active antiretroviral therapy.The Journal of infectious diseases, ,189 (8 ),1472-81

Sherman, Kenneth E (2004. )HCV and HIV: a tale of two viruses. Reviews in gastroenterological disorders, ,4 Suppl 1 ,S48-54

Shiramizu, Bruce; Theodore, Dickens; Bassett, Roland; Coel, Marc; Sherman, Kenneth E; Glesby, Marshall J; Chow, Dominic; Alston, Beverly; Colquhoun, Dodi; Merigan, Thomas C; Reichman, Richard C; Berggren, Ruth; Burning, Wendy Jo; Brobst, Susan (2003. )Correlation of single photon emission computed tomography parameters as a noninvasive alternative to liver biopsies in assessing liver involvement in the setting of HIV and hepatitis C virus coinfection: a multicenter trial of the Adult AIDS Clinical Trials Group. Journal of acquired immune deficiency syndromes (1999), ,33 (3 ),329-35

Keiserman, Daniela R; Both, Cristiane T; Mattos, Angelo A; Remiao, Jose; Alexandre, Claudio O P; Sherman, Kenneth E (2003. )Intrafamilial transmission of hepatitis C virus in patients with hepatitis C and human immunodeficiency virus coinfection.The American journal of gastroenterology, ,98 (4 ),878-83

Sherman, Kenneth E (2003. )Implications of peginterferon use in special populations infected with HCV.Seminars in liver disease, ,23 Suppl 1 ,47-52

Chung, Raymond T; Evans, Scott R; Yang, Yijun; Theodore, Dickens; Valdez, Hernan; Clark, Rebecca; Shikuma, Cecilia; Nevin, Thomas; Sherman, Kenneth E (2002. )Immune recovery is associated with persistent rise in hepatitis C virus RNA, infrequent liver test flares, and is not impaired by hepatitis C virus in co-infected subjects. AIDS (London, England), ,16 (14 ),1915-23

Goedert, James J; Eyster, M Elaine; Lederman, Michael M; Mandalaki, Titica; De Moerloose, Philippe; White, Gilbert C; Angiolillo, Anne L; Luban, Naomi L C; Sherman, Kenneth E; Manco-Johnson, Marilyn; Preiss, Liliana; Leissinger, Cindy; Kessler, Craig M; Cohen, Alan R; DiMichele, Donna; Hilgartner, Margaret W; Aledort, Louis M; Kroner, Barbara L; Rosenberg, Philip S; Hatzakis, Angelos (2002. )End-stage liver disease in persons with hemophilia and transfusion-associated infections. Blood, ,100 (5 ),1584-9

Sherman, Kenneth E; Rouster, Susan D; Horn, Paul S (2002. )Comparison of methodologies for quantification of hepatitis C virus (HCV) RNA in patients coinfected with HCV and human immunodeficiency virus.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, ,35 (4 ),482-7

Ajayi, Thomas; Sherman, Kenneth; Tang, Qisheng (2002. )Support of marine sustainability science. Science (New York, N.Y.), ,297 (5582 ),772

Bleau, Brian L; Gostout, Christopher J; Sherman, Kenneth E; Shaw, Michael J; Harford, William V; Keate, Ray F; Bracy, Waldo P; Fleischer, David E (2002. )Recurrent bleeding from peptic ulcer associated with adherent clot: a randomized study comparing endoscopic treatment with medical therapy. Gastrointestinal endoscopy, ,56 (1 ),1-6

Sherman, Kenneth E (2002. )Diagnosis and management of the HCV/HIV-coinfected patient. AIDS clinical care, ,14 (5 ),39-43, 48

Sherman, Kenneth E; Rouster, Susan D; Chung, Raymond T; Rajicic, Natasa (2002. )Hepatitis C Virus prevalence among patients infected with Human Immunodeficiency Virus: a cross-sectional analysis of the US adult AIDS Clinical Trials Group.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, ,34 (6 ),831-7

Butt, Adeel Ajwad; Yan, Peng; Shaikh, Obaid S; Lo Re, Vincent; Abou-Samra, Abdul-Badi; Sherman, Kenneth E (2020. )Treatment of HCV reduces viral hepatitis-associated liver-related mortality in patients: An ERCHIVES study.Journal of hepatology, ,73 (2 ),277-284

Butt, Adeel A; Yan, Peng; Aslam, Samia; Abou-Samra, Abdul-Badi; Sherman, Kenneth E; Shaikh, Obaid S (2020. )Liver Fibrosis Progression and Mortality in Hepatitis B- and C-Coinfected Persons Treated With Directly Acting Antiviral Agents: Results From ERCHIVES.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, ,71 (3 ),664-666

Bari, Khurram; Shah, Shimul A; Kaiser, Tiffany E; Cohen, Robert M; Anwar, Nadeem; Kleesattel, David; Sherman, Kenneth E (2020. )Safety and Efficacy of Budesonide for Liver Transplant Immune Suppression: Results of a Pilot Phase 2a trial.Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society, ,

Eckman, Mark H; Woodle, E Steve; Thakar, Charuhas V; Alloway, Rita R; Sherman, Kenneth E (2020. )Cost-effectiveness of Using Kidneys From HCV-Viremic Donors for Transplantation Into HCV-Uninfected Recipients.American journal of kidney diseases : the official journal of the National Kidney Foundation, ,75 (6 ),857-867

Abdel-Hameed, Enass A; Rouster, Susan D; Kottilil, Shyam; Sherman, Kenneth E (2020. )The enhanced liver fibrosis (ELF)-Index predicts hepatic fibrosis superior to FIB4 and APRI in HIV/HCV infected patients.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, ,

Seth, Aradhna; Sherman, Kenneth E (2020. )Editorial: HCV Cure is the Start of the End For Those With Advanced Fibrosis/Cirrhosis.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, ,

Sherman, Kenneth E; Abdel-Hameed, Enass A; Ehman, Richard L; Rouster, Susan D; Campa, Adriana; Martinez, Sabrina Sales; Huang, Yongjun; Zarini, Gustavo G; Hernandez, Jacqueline; Teeman, Colby; Tamargo, Javier; Liu, Qingyun; Mandler, Raul; Baum, Marianna K (2020. )Validation and Refinement of Noninvasive Methods to Assess Hepatic Fibrosis: Magnetic Resonance Elastography Versus Enhanced Liver Fibrosis Index.Digestive diseases and sciences, ,65 (4 ),1252-1257

Seth, Aradhna; Sherman, Kenneth E (2020. )Hepatitis E: What We Think We Know.Clinical liver disease, ,15 (Suppl 1 ),S37-S44

Butt, Adeel A; Yan, Peng; Aslam, Samia; Sherman, Kenneth E; Siraj, Dawd; Safdar, Nasia; Hameed, Bilal (2020. )Hepatitis C virologic response in hepatitis B and C coinfected persons treated with directly acting antiviral agents: Results from ERCHIVES.International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, ,92 ,184-188

Zarini, Gustavo; Sales Martinez, Sabrina; Campa, Adriana; Sherman, Kenneth; Tamargo, Javier; Hernandez Boyer, Jacqueline; Teeman, Colby; Johnson, Angelique; Degarege, Abraham; Greer, Pedro; Liu, Qingyun; Huang, Yongjun; Mandler, Raul; Choi, David; Baum, Marianna K (2020. )Sex Differences, Cocaine Use, and Liver Fibrosis Among African Americans in the Miami Adult Studies on HIV Cohort.Journal of women's health (2002), ,

Blackard, Jason T; Kwara, Awewura; Sherman, Kenneth E (2019. )In response to identification of a quadruple mutation that confers tenofovir resistance in chronic hepatitis B patients.Journal of hepatology, ,71 (6 ),1259-1260

Blackard, Jason T; Kong, Ling; Rouster, Susan D; Karns, Rebekah; Horn, Paul S; Kottilil, Shyam; Shata, M Tarek; Sherman, Kenneth E (2019. )CCR5 receptor antagonism inhibits hepatitis C virus (HCV) replication in vitro.PloS one, ,14 (10 ),e0224523

Farooq, Priya D; Sherman, Kenneth E (2019. )Hepatitis B Vaccination and Waning Hepatitis B Immunity in Persons Living with HIV.Current HIV/AIDS reports, ,16 (5 ),395-403

Sherman, Kenneth E; Peters, Marion G; Thomas, David L (2019. )HIV and the liver. Topics in antiviral medicine, ,27 (3 ),101-110

Dao, Ann; Cuffy, Madison; Kaiser, Tiffany E; Loethen, Ashley; Cafardi, John; Luckett, Keith; Rike, Adele Helen; Cardi, Michael; Alloway, Rita R; Govil, Amit; Diwan, Tayyab; Sherman, Kenneth E; Shah, Shimul A; Woodle, Ervin Steve (2019. )Use of HCV Ab+/NAT- donors in HCV naïve renal transplant recipients to expand the kidney donor pool.Clinical transplantation, ,33 (7 ),e13598

Hu, Ke-Qin; Cui, Wei; Rouster, Susan D; Sherman, Kenneth E (2019. )Hepatitis C virus antigens enzyme immunoassay for one-step diagnosis of hepatitis C virus coinfection in human immunodeficiency virus infected individuals.World journal of hepatology, ,11 (5 ),442-449

Sherman, Kenneth E; Abdel-Hameed, Enass; Rouster, Susan D; Shata, Mohamed Tarek M; Blackard, Jason T; Safaie, Parham; Kroner, Barbara; Preiss, Liliana; Horn, Paul S; Kottilil, Shyam (2019. )Improvement in Hepatic Fibrosis Biomarkers Associated With Chemokine Receptor Inactivation Through Mutation or Therapeutic Blockade.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, ,68 (11 ),1911-1918

Seth, Aradhna; Sherman, Kenneth E (2019. )Fatty liver disease in persons with HIV infection. Topics in antiviral medicine, ,27 (2 ),75-82

Eckman, Mark H; Ward, John W; Sherman, Kenneth E (2019. )Cost Effectiveness of Universal Screening for Hepatitis C Virus Infection in the Era of Direct-Acting, Pangenotypic Treatment Regimens.Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association, ,17 (5 ),930-939.e9

Narayanan, Shivakumar; Abutaleb, Ameer; Sherman, Kenneth E; Kottilil, Shyam (2019. )Clinical features and determinants of chronicity in hepatitis E virus infection.Journal of viral hepatitis, ,26 (4 ),414-421

Sherman, Kenneth E; Rouster, Susan D; Kong, Ling X; Aliota, Matthew T; Blackard, Jason T; Dean, Gary E (2019. )Zika virus replication and cytopathic effects in liver cells.PloS one, ,14 (3 ),e0214016

Foster, Graham R; Dore, Gregory J; Wang, Stanley; Grebely, Jason; Sherman, Kenneth E; Baumgarten, Axel; Conway, Brian; Jackson, Daniel; Asselah, Tarik; Gschwantler, Michael; Tomasiewicz, Krzysztof; Aguilar, Humberto; Asatryan, Armen; Hu, Yiran; Mensa, Federico J (2019. )Glecaprevir/pibrentasvir in patients with chronic HCV and recent drug use: An integrated analysis of 7 phase III studies.Drug and alcohol dependence, ,194 ,487-494

Shata, Mohamed Tarek M; Abdel-Hameed, Enass A; Rouster, Susan D; Yu, Li; Liang, Meina; Song, Esther; Esser, Mark T; Shire, Norah; Sherman, Kenneth E (2019. )HBV and HIV/HBV Infected Patients Have Distinct Immune Exhaustion and Apoptotic Serum Biomarker Profiles.Pathogens & immunity, ,4 (1 ),39-65

Eckman, Mark H; Woodle, E Steve; Thakar, Charuhas V; Paterno, Flavio; Sherman, Kenneth E (2018. )Transplanting Hepatitis C Virus-Infected or Uninfected Kidneys Into Hepatitis C Virus-Infected Recipients.Annals of internal medicine, ,169 (12 ),898-899

Sherman, Kenneth E; Rouster, Susan D; Kang, Minhee; Umbleja, Triin; Sterling, Richard; Butt, Adeel A (2018. )PNPLA3 Gene Polymorphisms in HCV/HIV-Coinfected Individuals.Digestive diseases and sciences, ,63 (11 ),2969-2974

Abutaleb, Ameer; Sherman, Kenneth E (2018. )A changing paradigm: management and treatment of the HCV/HIV-co-infected patient.Hepatology international, ,12 (6 ),500-509

Anwar, Nadeem; Sherman, Kenneth E (2018. )Transplanting organs from hepatitis B positive donors: Is it safe? Is it ethical?.Journal of viral hepatitis, ,25 (10 ),1110-1115

Rockstroh, Jürgen K; Lacombe, Karine; Viani, Rolando M; Orkin, Chloe; Wyles, David; Luetkemeyer, Anne F; Soto-Malave, Ruth; Flisiak, Robert; Bhagani, Sanjay; Sherman, Kenneth E; Shimonova, Tatiana; Ruane, Peter; Sasadeusz, Joseph; Slim, Jihad; Zhang, Zhenzhen; Samanta, Suvajit; Ng, Teresa I; Gulati, Abhishek; Kosloski, Matthew P; Shulman, Nancy S; Trinh, Roger; Sulkowski, Mark (2018. )Efficacy and Safety of Glecaprevir/Pibrentasvir in Patients Coinfected With Hepatitis C Virus and Human Immunodeficiency Virus Type 1: The EXPEDITION-2 Study.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, ,67 (7 ),1010-1017

Eckman, Mark H; Woodle, E Steve; Thakar, Charuhas V; Paterno, Flavio; Sherman, Kenneth E (2018. )Transplanting Hepatitis C Virus-Infected Versus Uninfected Kidneys Into Hepatitis C Virus-Infected Recipients: A Cost-Effectiveness Analysis.Annals of internal medicine, ,169 (4 ),214-223

Sherman, Kenneth E; Rouster, Susan D; Kong, Ling X; Shata, Tarek M; Archampong, Timothy; Kwara, Awewura; Aliota, Matthew T; Blackard, Jason T (2018. )Zika Virus Exposure in an HIV-Infected Cohort in Ghana.Journal of acquired immune deficiency syndromes (1999), ,78 (5 ),e35-e38

Blackard, Jason T; Sherman, Kenneth E (2018. )Hepatitis B virus (HBV) reactivation-The potential role of direct-acting agents for hepatitis C virus (HCV).Reviews in medical virology, ,28 (4 ),e1984

Safaie, Parham; Razeghi, Sanam; Rouster, Susan D; Privitera, Isaac; Sherman, Kenneth E (2018. )Hepatitis D diagnostics:Utilization and testing in the United States.Virus research, ,250 ,114-117

Bari, Khurram; Luckett, Keith; Kaiser, Tiffany; Diwan, Tayyab; Cuffy, Madison; Schoech, Michael R; Safdar, Kamran; Blackard, Jason T; Apewokin, Senu; Paterno, Flavio; Sherman, Kenneth E; Zucker, Stephen D; Anwar, Nadeem; Shah, Shimul A (2018. )Hepatitis C transmission from seropositive, nonviremic donors to non-hepatitis C liver transplant recipients.Hepatology (Baltimore, Md.), ,67 (5 ),1673-1682

Abdel-Hameed, Enass A; Rouster, Susan D; Boyce, Ceejay L; Zhang, Xiang; Biesiada, Jacek; Medvedovic, Mario; Sherman, Kenneth E (2018. )Ultra-Deep Genomic Sequencing of HCV NS5A Resistance-Associated Substitutions in HCV/HIV Coinfected Patients.Digestive diseases and sciences, ,63 (3 ),645-652

Wang, Gary P; Terrault, Norah; Reeves, Jacqueline D; Liu, Lin; Li, Eric; Zhao, Lisa; Lim, Joseph K; Morelli, Giuseppe; Kuo, Alexander; Levitsky, Josh; Sherman, Kenneth E; Frazier, Lynn M; Ramani, Ananthakrishnan; Peter, Joy; Akuskevich, Lucy; Fried, Michael W; Nelson, David R (2018. )Prevalence and impact of baseline resistance-associated substitutions on the efficacy of ledipasvir/sofosbuvir or simeprevir/sofosbuvir against GT1 HCV infection.Scientific reports, ,8 (1 ),3199

Sherman, Kenneth E; Shah, Vijay H (2018. )Viral Hepatitis: Knowledge and Treatments for Hepatitis B and C Virus and Associated Transplantation and Neoplasia.Gastroenterology, ,154 (3 ),453-456

Shive, Carey L; Judge, Chelsey J; Clagett, Brian; Kalayjian, Robert C; Osborn, Melissa; Sherman, Kenneth E; Fichtenbaum, Carl; Gandhi, Rajesh T; Kang, Minhee; Popkin, Daniel L; Sieg, Scott F; Lederman, Michael M; Rodriguez, Benigno; Anthony, Donald D (2018. )Pre-vaccine plasma levels of soluble inflammatory indices negatively predict responses to HAV, HBV, and tetanus vaccines in HCV and HIV infection.Vaccine, ,36 (4 ),453-460

Kiser, Jennifer J; Lu, Darlene; Rosenkranz, Susan L; Morse, Gene D; DiFrancesco, Robin; Sherman, Kenneth E; Butt, Adeel A (2017. )Boceprevir and Antiretroviral Pharmacokinetic Interactions in HIV/HCV Co-infected Persons: AIDS Clinical Trials Group Study A5309s.Drugs in R&D, ,17 (4 ),557-567

Sherman, Kenneth E; Peters, Marion G; Thomas, David (2017. )Human immunodeficiency virus and liver disease: A comprehensive update.Hepatology communications, ,1 (10 ),987-1001

Murrison, Liza Bronner; Sherman, Kenneth E (2017. )The Enigma of Hepatitis E Virus. Gastroenterology & hepatology, ,13 (8 ),484-491

Judge, Chelsey J; Kostadinova, Lenche; Sherman, Kenneth E; Butt, Adeel A; Falck-Ytter, Yngve; Funderburg, Nicholas T; Landay, Alan L; Lederman, Michael M; Sieg, Scott F; Sandberg, Johan K; Anthony, Donald D (2017. )CD56bright NK IL-7R? expression negatively associates with HCV level, and IL-7-induced NK function is impaired during HCV and HIV infections.Journal of leukocyte biology, ,102 (1 ),171-184

Ragni, Margaret V; Humar, Abhinav; Stock, Peter G; Blumberg, Emily A; Eghtesad, Bijan; Fung, John J; Stosor, Valentina; Nissen, Nicholas; Wong, Michael T; Sherman, Kenneth E; Stablein, Donald M; Barin, Burc (2017. )Hemophilia Liver Transplantation Observational Study.Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society, ,23 (6 ),762-768

Soriano, Vincent; Sherman, Kenneth E; Barreiro, Pablo (2017. )Hepatitis delta and HIV infection.AIDS (London, England), ,31 (7 ),875-884

Abdel-Hameed, Enass A; Rouster, Susan D; Zhang, Xiang; Chen, Jing; Medvedovic, Mario; Goodman, Zachary D; Sherman, Kenneth E (2017. )Characterization of HCV NS3 Protease Variants in HCV/HIV-Coinfected Patients by Ultra-Deep Sequence Analysis: Relationship with Hepatic Fibrosis.Journal of acquired immune deficiency syndromes (1999), ,74 (3 ),353-358

Sherman, Kenneth E; Kang, Minhee; Sterling, Richard; Umbleja, Triin; Marks, Kristen; Kiser, Jennifer J; Alston-Smith, Beverly; Greaves, Wayne; Butt, Adeel A; The Actg Birth Study Team, (2017. )Phase 3 trial of first generation protease inhibitor therapy for hepatitis C virus/human immunodeficiency virus coinfection.World journal of hepatology, ,9 (4 ),217-223

Butt, A A; Ren, Y; Marks, K; Shaikh, O S; Sherman, K E (2017. )Do directly acting antiviral agents for HCV increase the risk of hepatic decompensation and decline in renal function? Results from ERCHIVES.Alimentary pharmacology & therapeutics, ,45 (1 ),150-159

Mehta, Minesh; Hetta, Helal F; Abdel-Hameed, Enass A; Rouster, Susan D; Hossain, MdMonir; Mekky, Mohamed A; Khalil, Nasr K; Mohamed, Wegdan A; El-Feky, Mohamed A; Ahmed, Shabaan H; Daef, Enas A; El-Mokhtar, Mohamed A; Abdelwahab, Sayed F; Medhat, Ahmed; Sherman, Kenneth E; Shata, Mohamed Tarek M (2016. )Association between IL28B rs12979860 single nucleotide polymorphism and the frequency of colonic Treg in chronically HCV-infected patients.Archives of virology, ,161 (11 ),3161-9

Judge, Chelsey J; Sandberg, Johan K; Funderburg, Nicholas T; Sherman, Kenneth E; Butt, Adeel A; Kang, Minhee; Landay, Alan L; Lederman, Michael M; Anthony, Donald D (2016. )Brief Report: CD14brightCD16- monocytes and sCD14 level negatively associate with CD4-memory T-cell frequency and predict HCV-decline on therapy.Journal of acquired immune deficiency syndromes (1999), ,73 (3 ),258-262

Acquavita, Shauna P; Kauffman, Sandra S; Talks, Alexandra; Sherman, Kate Pregnant women with substance use disorders: The intersection of history, ethics, and advocacy.Social work in health care, ,55 (10 ),843-860

Butt, A A; Yan, P; Marks, K; Shaikh, O S; Sherman, K E (2016. )Adding ribavirin to newer DAA regimens does not affect SVR rates in HCV genotype 1 infected persons: results from ERCHIVES.Alimentary pharmacology & therapeutics, ,44 (7 ),728-37

Feld, Jordan J; Maan, Raoel; Zeuzem, Stefan; Kuo, Alexander; Nelson, David R; Di Bisceglie, Adrian M; Manns, Michael P; Sherman, Ken; Frazier, Lynn M; Sterling, Richard; Mailliard, Mark; Schmidt, Monica; Akushevich, Lucy; Vainorius, Monika; Fried, Michael W (2016. )Effectiveness and Safety of Sofosbuvir-Based Regimens for Chronic HCV Genotype 3 Infection: Results of the HCV-TARGET Study.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, ,63 (6 ),776-783

Butt, Adeel A; Yan, Peng; Shaikh, Obaid S; Chung, Raymond T; Sherman, Kenneth E (2016. )Treatment adherence and virological response rates in hepatitis C virus infected persons treated with sofosbuvir-based regimens: results from ERCHIVES.Liver international : official journal of the International Association for the Study of the Liver, ,36 (9 ),1275-83

Hetta, Helal F; Mekky, Mohamed A; Khalil, Nasr K; Mohamed, Wegdan A; El-Feky, Mohamed A; Ahmed, Shabaan H; Daef, Enas A; Medhat, Ahmed; Nassar, Mahmoud I; Sherman, Kenneth E; Shata, Mohamed Tarek M (2016. )Extra-hepatic infection of hepatitis C virus in the colon tissue and its relationship with hepatitis C virus pathogenesis.Journal of medical microbiology, ,65 (8 ),703-712

Sherman, K E; Ke, R; Rouster, S D; Abdel-Hameed, E A; Park, C; Palascak, J; Perelson, A S (2016. )Viral dynamic modelling of Hepatitis C and resistance-associated variants in haemophiliacs.Haemophilia : the official journal of the World Federation of Hemophilia, ,22 (4 ),543-8

Blackard, Jason T; Ma, Gang; Polen, Clarissa; DuBois, Juwen C; Gast, Jonathon; Radens, Caleb M; Sterling, Richard K; Sherman, Kenneth E (2016. )Recombination among GB virus C (GBV-C) isolates in the United States.The Journal of general virology, ,97 (7 ),1537-1544

Lyons, Michael S; Kunnathur, Vidhya A; Rouster, Susan D; Hart, Kimberly W; Sperling, Matthew I; Fichtenbaum, Carl J; Sherman, Kenneth E (2016. )Prevalence of Diagnosed and Undiagnosed Hepatitis C in a Midwestern Urban Emergency Department.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, ,62 (9 ),1066-71

Butt, Adeel A; Yan, Peng; Shaikh, Obaid S; Chung, Raymond T; Sherman, Kenneth E (2016. )Sofosbuvir-based regimens in clinical practice achieve SVR rates closer to clinical trials: results from ERCHIVES.Liver international : official journal of the International Association for the Study of the Liver, ,36 (5 ),651-8

Abdel-Hameed, Enass A; Rouster, Susan D; Ji, Hong; Ulm, Ashley; Hetta, Helal F; Anwar, Nadeem; Sherman, Kenneth E; Shata, Mohamed Tarek M (2016. )Evaluating the Role of Cellular Immune Responses in the Emergence of HCV NS3 Resistance Mutations During Protease Inhibitor Therapy.Viral immunology, ,29 (4 ),252-8

Reau, Nancy; Fried, Michael W; Nelson, David R; Brown, Robert S; Everson, Gregory T; Gordon, Stuart C; Jacobson, Ira M; Lim, Joseph K; Pockros, Paul J; Reddy, K Rajender; Sherman, Kenneth E (2016. )HCV Council--critical appraisal of data: recommendations for clinical practice in a rapidly evolving therapeutic landscape.Liver international : official journal of the International Association for the Study of the Liver, ,36 (4 ),488-502

Campa, Adriana; Martinez, Sabrina Sales; Sherman, Kenneth E; Greer, Joe Pedro; Li, Yinghui; Garcia, Stephanie; Stewart, Tiffanie; Ibrahimou, Boubakari; Williams, O Dale; Baum, Marianna K (2016. )Cocaine Use and Liver Disease are Associated with All-Cause Mortality in the Miami Adult Studies in HIV (MASH) Cohort.Journal of drug abuse, ,2 (4 ),

Shire, Norah J; Sherman, Kenneth E (2015. )Epidemiology of Hepatitis C Virus: A Battle on New Frontiers.Gastroenterology clinics of North America, ,44 (4 ),699-716

Sherman, Kenneth E; Rockstroh, Juergen; Thomas, David (2015. )Human immunodeficiency virus and liver disease: An update.Hepatology (Baltimore, Md.), ,62 (6 ),1871-82

Hetta, Helal F; Mekky, Mohamed A; Khalil, Nasr K; Mohamed, Wegdan A; El-Feky, Mohamed A; Ahmed, Shabaan H; Daef, Enas A; Nassar, Mahmoud I; Medhat, Ahmed; Sherman, Kenneth E; Shata, Mohamed Tarek M (2015. )Association of colonic regulatory T cells with hepatitis C virus pathogenesis and liver pathology.Journal of gastroenterology and hepatology, ,30 (10 ),1543-51

Butt, A A; Yan, P; Shaikh, O S; Freiberg, M S; Lo Re, V; Justice, A C; Sherman, K E (2015. )Virologic response and haematologic toxicity of boceprevir- and telaprevir-containing regimens in actual clinical settings.Journal of viral hepatitis, ,22 (9 ),691-700

Wyles, David L; Ruane, Peter J; Sulkowski, Mark S; Dieterich, Douglas; Luetkemeyer, Anne; Morgan, Timothy R; Sherman, Kenneth E; Dretler, Robin; Fishbein, Dawn; Gathe, Joseph C; Henn, Sarah; Hinestrosa, Federico; Huynh, Charles; McDonald, Cheryl; Mills, Anthony; Overton, Edgar Turner; Ramgopal, Moti; Rashbaum, Bruce; Ray, Graham; Scarsella, Anthony; Yozviak, Joseph; McPhee, Fiona; Liu, Zhaohui; Hughes, Eric; Yin, Philip D; Noviello, Stephanie; Ackerman, Peter (2015. )Daclatasvir plus Sofosbuvir for HCV in Patients Coinfected with HIV-1.The New England journal of medicine, ,373 (8 ),714-25

Sherman, Kenneth E Management of the Hepatitis B Virus/HIV-Coinfected Patient. Topics in antiviral medicine, ,23 (3 ),111-4

Jensen, Donald; Sherman, Kenneth E; Hézode, Christophe; Pol, Stanislas; Zeuzem, Stefan; de Ledinghen, Victor; Tran, Albert; Elkhashab, Magdy; Younes, Ziad H; Kugelmas, Marcelo; Mauss, Stefan; Everson, Gregory; Luketic, Velimir; Vierling, John; Serfaty, Lawrence; Brunetto, Maurizia; Heo, Jeong; Bernstein, David; McPhee, Fiona; Hennicken, Delphine; Mendez, Patricia; Hughes, Eric; Noviello, Stephanie (2015. )Daclatasvir and asunaprevir plus peginterferon alfa and ribavirin in HCV genotype 1 or 4 non-responders.Journal of hepatology, ,63 (1 ),30-7

Butt, Adeel A; Yan, Peng; Lo Re, Vincent; Rimland, David; Goetz, Matthew B; Leaf, David; Freiberg, Matthew S; Klein, Marina B; Justice, Amy C; Sherman, Kenneth E (2015. )Liver fibrosis progression in hepatitis C virus infection after seroconversion.JAMA internal medicine, ,175 (2 ),178-85

Anwar, Nadeem; Sherman, Kenneth E (2014. )HCV treatment of special populations: HIV coinfected, liver transplant, and renal failure.Clinical liver disease, ,4 (4 ),80-83

Lin, M V; Charlton, A N; Rouster, S D; Zamor, P J; Sherman, K E (2014. )Hepatitis C virus NS3 mutations in haemophiliacs.Haemophilia : the official journal of the World Federation of Hemophilia, ,20 (5 ),659-65

Blackard, Jason T; Ma, Gang; Sengupta, Satarupa; Martin, Christina M; Powell, Eleanor A; Shata, M Tarek; Sherman, Kenneth E (2014. )Evidence of distinct populations of hepatitis C virus in the liver and plasma of patients co-infected with HIV and HCV.Journal of medical virology, ,86 (8 ),1332-41

Sherman, K E; Terrault, N; Barin, B; Rouster, S D; Shata, M T (2014. )Hepatitis E infection in HIV-infected liver and kidney transplant candidates.Journal of viral hepatitis, ,21 (8 ),e74-7

Sherman, Kenneth E; Guedj, Jeremie; Shata, Mohamed Tarek; Blackard, Jason T; Rouster, Susan D; Castro, Mario; Feinberg, Judith; Sterling, Richard K; Goodman, Zachary; Aronow, Bruce J; Perelson, Alan S (2014. )Modulation of HCV replication after combination antiretroviral therapy in HCV/HIV co-infected patients.Science translational medicine, ,6 (246 ),246ra98

Schmidt, Warren N; Nelson, David R; Pawlotsky, Jean-Michel; Sherman, Kenneth E; Thomas, David L; Chung, Raymond T (2014. )Direct-acting antiviral agents and the path to interferon independence.Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association, ,12 (5 ),728-37

Sherman, Kenneth E; Thomas, David; Chung, Raymond T (2014. )Human immunodeficiency virus and liver disease forum 2012.Hepatology (Baltimore, Md.), ,59 (1 ),307-17

Abdel-Hameed, Enass A; Ji, Hong; Sherman, Kenneth E; Shata, Mohamed T M (2014. )Epigenetic modification of FOXP3 in patients with chronic HIV infection.Journal of acquired immune deficiency syndromes (1999), ,65 (1 ),19-26

Shata, Mohamed Tarek M; Abdel-Hameed, Enass A; Hetta, Helal F; Sherman, Kenneth E (2013. )Immune activation in HIV/HCV-infected patients is associated with low-level expression of liver expressed antimicrobial peptide-2 (LEAP-2).Journal of clinical pathology, ,66 (11 ),967-75

Sherman, Kenneth E (2012. )Therapeutic approach to the treatment-naive patient with hepatitis C virus genotype 1 infection: a step-by-step approach.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, ,55 (9 ),1236-41

Kemmer, N; Hua, L; Andersen, J W; Chung, R T; Butt, A A; Sherman, K E (2012. )Health-related quality of life in subjects with HCV/HIV coinfection: results from ACTG 5178 study.Journal of viral hepatitis, ,19 (11 ),792-800

Martin, C M; Welge, J A; Rouster, S D; Shata, M T; Sherman, K E; Blackard, J T (2012. )Mutations associated with occult hepatitis B virus infection result in decreased surface antigen expression in vitro.Journal of viral hepatitis, ,19 (10 ),716-23

Sherman, Kenneth E Managing adverse effects and complications in completing treatment for hepatitis C virus infection. Topics in antiviral medicine, ,20 (4 ),125-8

Shata, Mohamed T; Daef, Enas A; Zaki, Maysaa E; Abdelwahab, Sayed F; Marzuuk, Naglaa M; Sobhy, Maha; Rafaat, Marwa; Abdelbaki, Liala; Nafeh, Mohamed A; Hashem, Mohamed; El-Kamary, Samer S; Shardell, Michelle D; Mikhail, Nabiel N; Strickland, George T; Sherman, Kenneth E (2012. )Protective role of humoral immune responses during an outbreak of hepatitis E in Egypt.Transactions of the Royal Society of Tropical Medicine and Hygiene, ,106 (10 ),613-8

Jennings, Carrie L; Sherman, Kenneth E (2012. )Hepatitis C and HIV co-infection: new drugs in practice and in the pipeline.Current HIV/AIDS reports, ,9 (3 ),231-7

Kong, Ling; Cardona Maya, Walter; Moreno-Fernandez, Maria E; Ma, Gang; Shata, Mohamed T; Sherman, Kenneth E; Chougnet, Claire; Blackard, Jason T (2012. )Low-level HIV infection of hepatocytes.Virology journal, ,9 ,157

Blackard, Jason T; Ma, Gang; Welge, Jeffrey A; Martin, Christina M; Sherman, Kenneth E; Taylor, Lynn E; Mayer, Kenneth H; Jamieson, Denise J (2012. )Analysis of a non-structural gene reveals evidence of possible hepatitis C virus (HCV) compartmentalization.Journal of medical virology, ,84 (2 ),242-52

Sherman, Kenneth E; Thomas, David L; Chung, Raymond T (2011. )Human immunodeficiency virus and liver disease forum 2010: conference proceedings.Hepatology (Baltimore, Md.), ,54 (6 ),2245-53

Hernandez, Maria D; Sherman, Kenneth E (2011. )HIV/hepatitis C coinfection natural history and disease progression.Current opinion in HIV and AIDS, ,6 (6 ),478-82

Kemmer, Nyingi M; Sherman, Kenneth E (2011. )Liver transplantation trends in the HIV population.Digestive diseases and sciences, ,56 (11 ),3393-8

Sherman, Kenneth E (2011. )Hepatitis e virus infection: more common than previously realized? .Gastroenterology & hepatology, ,7 (11 ),759-61

Sherman, Kenneth E; Flamm, Steven L; Afdhal, Nezam H; Nelson, David R; Sulkowski, Mark S; Everson, Gregory T; Fried, Michael W; Adler, Michael; Reesink, Hendrik W; Martin, Marie; Sankoh, Abdul J; Adda, Nathalie; Kauffman, Robert S; George, Shelley; Wright, Christopher I; Poordad, Fred (2011. )Response-guided telaprevir combination treatment for hepatitis C virus infection.The New England journal of medicine, ,365 (11 ),1014-24

Sherman, Kenneth E Advanced liver disease: what every hepatitis C virus treater should know. Topics in antiviral medicine, ,19 (3 ),121-5

Martin, C M; Welge, J A; Shire, N J; Rouster, S D; Shata, M T; Sherman, K E; Blackard, J T (2010. )Genomic variability associated with the presence of occult hepatitis B virus in HIV co-infected individuals.Journal of viral hepatitis, ,17 (8 ),588-97

Rashkin, S; Rouster, S; Goodman, Z D; Sherman, K E (2010. )T-helper cells and liver fibrosis in hepatitis C virus-monoinfected patients.Journal of viral hepatitis, ,17 (3 ),222-6

Dichiara, A J; Atkinson, M; Goodman, Z; Sherman, K E (2008. )Ciprofloxacin-induced acute cholestatic liver injury and associated renal failure. Case report and review. Minerva gastroenterologica e dietologica, ,54 (3 ),307-15

Blackard, J T; Sherman, K E (2008. )HCV/ HIV co-infection: time to re-evaluate the role of HIV in the liver?.Journal of viral hepatitis, ,15 (5 ),323-30

Shata, M T; Barrett, A; Shire, N J; Abdelwahab, S F; Sobhy, M; Daef, E; El-Kamary, S S; Hashem, M; Engle, R E; Purcell, R H; Emerson, S U; Strickland, G T; Sherman, K E (2007. )Characterization of hepatitis E-specific cell-mediated immune response using IFN-gamma ELISPOT assay.Journal of immunological methods, ,328 (1-2 ),152-61

Shire, N J; Welge, J A; Sherman, K E (2007. )Response rates to pegylated interferon and ribavirin in HCV/HIV coinfection: a research synthesis.Journal of viral hepatitis, ,14 (4 ),239-48

Neff, Guy W; Jayaweera, Dushyantha; Sherman, Kenneth E (2006. )Drug-Induced Liver Injury in HIV Patients. Gastroenterology & hepatology, ,2 (6 ),430-437

Lienesch, D W; Sherman, K E; Metzger, A; Shen, G Q Anti-Clq antibodies in patients with chronic hepatitis C infection. Clinical and experimental rheumatology, ,24 (2 ),183-5

Shire, N J; Sherman, K E (2006. )Management of hepatitis B virus in HIV-positive patients. Minerva gastroenterologica e dietologica, ,52 (1 ),67-87

Neff, G W; Sherman, K E; Eghtesad, B; Fung, J (2004. )Review article: current status of liver transplantation in HIV-infected patients.Alimentary pharmacology & therapeutics, ,20 (10 ),993-1000

Sherman, K E; Rouster, S D; Feinberg, J (2001. )Prevalence and genotypic variability of TTV in HIV-infected patients.Digestive diseases and sciences, ,46 (11 ),2401-7

Zucker, S D; Qin, X; Rouster, S D; Yu, F; Green, R M; Keshavan, P; Feinberg, J; Sherman, K E (2001. )Mechanism of indinavir-induced hyperbilirubinemia.Proceedings of the National Academy of Sciences of the United States of America, ,98 (22 ),12671-6

Meyer, C A; White, C S; Sherman, K E Diseases of the hepatopulmonary axis.Radiographics : a review publication of the Radiological Society of North America, Inc, ,20 (3 ),687-98

Mendenhall, C L; Finkelman, F; Means, R T; Sherman, K E; Nguyen, V T; Grossman, C E; Morris, S C; Rouster, S; Roselle, G A (1999. )Cytokine response to BCG infection in alcohol-fed mice.Alcohol (Fayetteville, N.Y.), ,19 (1 ),57-63

Sherman, K E; Rouster, S D; Mendenhall, C; Thee, D (1999. )Hepatitis cRNA quasispecies complexity in patients with alcoholic liver disease.Hepatology (Baltimore, Md.), ,30 (1 ),265-70

Manocha, A P; Sossenheimer, M; Martin, S P; Sherman, K E; Venkatesan, T; Whitcomb, D C; Ulrich, C D (1999. )Prevalence and predictors of severe acute pancreatitis in patients with acquired immune deficiency syndrome (AIDS).The American journal of gastroenterology, ,94 (3 ),784-9

Sherman, K E; Sickler, J; Aranda-Michel, J; Weber, F L; Martin, S; Whiting, J; Hanto, D (1999. )Rimantadine for treatment of hepatitis C infection in liver transplant recipients.Liver transplantation and surgery : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society, ,5 (1 ),25-8

Sherman, K E; Sjogren, M; Creager, R L; Damiano, M A; Freeman, S; Lewey, S; Davis, D; Root, S; Weber, F L; Ishak, K G; Goodman, Z D (1998. )Combination therapy with thymosin alpha1 and interferon for the treatment of chronic hepatitis C infection: a randomized, placebo-controlled double-blind trial.Hepatology (Baltimore, Md.), ,27 (4 ),1128-35

Sickler, J B; Simmons, R A; Cobb, D K; Sherman, K E (1998. )Cutaneous necrosis associated with interferon alpha-2b.The American journal of gastroenterology, ,93 (3 ),463-4

Aranda-Michel, J; Sherman, K E (1998. )Tests of the liver: use and misuse. The Gastroenterologist, ,6 (1 ),34-43

Sherman, K E; Mendenhall, C; Thee, D L; O'Brien, J; Rouster, S D (1997. )Hepatitis C serotypes in nonalcoholic and alcoholic patients.Digestive diseases and sciences, ,42 (11 ),2285-91

Jain, R; McLaren, B; Bejarano, P; Sherman, K E (1996. )A 69-year-old man with cholestatic liver disease.Seminars in liver disease, ,16 (4 ),445-9

Sherman, K E; Andreatta, C; O'Brien, J; Gutierrez, A; Harris, R (1996. )Hepatitis C in human immunodeficiency virus-coinfected patients: increased variability in the hypervariable envelope coding domain.Hepatology (Baltimore, Md.), ,23 (4 ),688-94

Sherman, K E; Lewey, S M; Goodman, Z D (1995. )Talc in the liver of patients with chronic hepatitis C infection. The American journal of gastroenterology, ,90 (12 ),2164-6

Sise, Meghan E; Goldberg, David S; Kort, Jens J; Schaubel, Douglas E; Alloway, Rita R; Durand, Christine M; Fontana, Robert J; Brown, Robert S; Friedewald, John J; Prenner, Stacey; Landis, J Richard; Fernando, Melissa; Phillips, Caitlin C; Woodle, E Steve; Rike-Shields, Adele; Sherman, Kenneth E; Elias, Nahel; Williams, Winfred W; Gustafson, Jenna L; Desai, Niraj M; Barnaba, Brittany; Norman, Silas P; Doshi, Mona; Sultan, Samuel T; Aull, Meredith J; Levitsky, Josh; Belshe, Dianne S; Chung, Raymond T; Reese, Peter P (2020. )Multicenter Study to Transplant Hepatitis C-Infected Kidneys (MYTHIC): An Open-Label Study of Combined Glecaprevir and Pibrentasvir to Treat Recipients of Transplanted Kidneys from Deceased Donors with Hepatitis C Virus Infection.Journal of the American Society of Nephrology : JASN, ,

Honors and Awards

1979 Sigma Xi (National Research Honor Society)

1976 Alpha Zeta (National Agricultural Honor Society)

1976 -1980 Busch Pre-doctoral Fellow at the Waksman Institute for Microbiology

1976 B.S. with High Honors (Magna Cum)

1985 George Washington University Donald Glew Medical Student Research Award

1989 Army Achievement Medal (Research Activities)

1989 William Beaumont Award for Clinical Research in Gastroenterology

1994 Army Meritorious Service Medal

2005 Who's Who in America 59th Edition

2005 -2010 Best Doctors in America

Alpha Omega Alpha (AOA)

Keywords

Pharmacoepidemiology(MeSH PhrmEpi),Digestive System(MeSH A03),Viruses(MeSH B04),Virus Diseases(MeSH C02),Digestive System Diseases(MeSH C06),Nucleic Acids, Nucleotides, and Nucleosides(MeSH D13),Diagnosis(MeSH E01),Therapeutics(MeSH E02),Investigative Techniques(MeSH E05),Digestive, Oral, and Skin Physiology(MeSH G10)

Contact Information

Academic - Medical Sciences Building
231 Albert Sabin Way
Cincinnati  Ohio, 45267
Phone: 513-558-7200
Fax: 513-558-6013
shermake@ucmail.uc.edu